Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis

Award Number: R21DE031906
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2023
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis - Abstract Poorly controlled diabetes mellitus (DM) exacerbates periodontitis (PD) development and progression. In addition, the management of PD in patients with uncontrolled DM remains a clinical challenge. In fact, PD constitutes the sixth most frequent complication of DM. However, the mechanisms by which DM compounds PD are not fully understood, although a heightened inflammatory response plays a central role. Among the major inflammatory mediators of DM is CXCL10. Interestingly, CXCL10 also plays an important role in PD. CXCL10 expression levels are higher in periodontally diseased tissues and in the serum of patients with PD. Moreover, our laboratory has shown that the CXCL10-CXCR3 axis is fundamental for PD development. We demonstrated that experimentally-induced periodontal bone loss (EPD), in mice, is significantly reduced when the CXCL10 receptor CXCR3, is deleted. Moreover, systemic, and local delivery of a CXCR3 antagonist attenuates EPD, pointing to the targeting of CXCL10 as a potential intervention for PD. Given that DM exacerbates PD, and the key role of CXCL10 as an inflammatory mediator of DM and PD, we hypothesize that CXCL10 is central in mediating the detrimental effects of DM and PD. Thus, targeting the CXCL10-CXCR3 axis should ameliorate the deleterious effects of DM in the periodontium and is a potential therapeutic strategy for the periodontal management of patients with uncontrolled DM. To accomplish our goal, we have two specific aims (SA). SA1: Further elucidate the role of CXCL10 in the periodontium by deleting CXCL10 (SA1a) and by administering CXCL10 systemically (SA1b). SA2: Determine the inhibition of periodontal destruction by a CXCR3 antagonist in mice with DM. In this aim, we will evaluate if local delivery of nanoparticles containing a CXCR3 antagonist, AMG-487, could mitigate the effects of DM in the PD. In brief, DM will be induced in mice, EPD will be developed, and AMG-487 will be delivered locally in slow-releasing nanoparticles. These experiments will provide proof-of- principle evidence for targeting CXCL10-CXCR3 signaling in periodontal inflammation in patients with DM. The long-term goal of our research is to dissect the role of CXCL10 in the exacerbation of PD by DM and to lay the foundation for developing a novel therapeutic approach to assist in the periodontal treatment of patients with uncontrolled diabetes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2023	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Oral Diseases and Disorders Research	000	1	11/25/2025	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $432,209 )
2023	2023	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Oral Diseases and Disorders Research	000	1	7/21/2023	NEW	$432,209
														Subtotal = $432,209

Grand Total All Awards = $432,209

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis

Award Number: R21DE031906

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2023

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer